Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:0
|
作者
Dreyling, M. [1 ]
Ghielmini, M. [2 ]
Marcus, R. [3 ]
Salles, G. [4 ]
Vitolo, U. [5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Med 3, Munich, Germany
[2] Osped San Giovanni Bellinzona, Oncol Inst So Switzerland, Bellinzona, Switzerland
[3] Kings Coll Hosp London, London, England
[4] Ctr Hosp Lyon Sud, Serv Hematol, F-69310 Pierre Benite, France
[5] Ctr Univ Ric Oncol Osped Molinette, Turin, Italy
[6] ESMO Head Off, CH-6962 Viganello Lugano, Switzerland
关键词
STEM-CELL TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; NON-HODGKINS-LYMPHOMA; HIGH-DOSE THERAPY; HIGH-RISK; RITUXIMAB; CHEMOTHERAPY; INTERFERON; CHOP; CYCLOPHOSPHAMIDE;
D O I
10.1093/annonc/mdr388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
下载
收藏
页码:vi59 / vi63
页数:5
相关论文
共 50 条
  • [21] Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 24, pg 24, 2013)
    Ledermann, J. A.
    Raja, F. A.
    Fotopoulou, C.
    Gonzalez-Martin, A.
    Colombo, N.
    Sessa, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 259 - 259
  • [22] Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Guggenheim, M.
    Jost, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2010, 21 : v194 - v197
  • [23] Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Wiegel, T.
    Guix, M.
    De Santis, M.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2011, 22 : vi45 - vi49
  • [24] Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Berruti, A.
    Baudin, E.
    Gelderblom, H.
    Haak, H. R.
    Porpiglia, F.
    Fassnacht, M.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 131 - 138
  • [25] Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Fenaux, P.
    Haase, D.
    Sanz, G. F.
    Santini, V.
    Buske, C.
    ANNALS OF ONCOLOGY, 2014, 25 : 57 - 69
  • [26] Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Hogendoorn, P. C. W.
    Athanasou, N.
    Bielack, S.
    De Alava, E.
    Tos, A. P. Dei
    Ferrari, S.
    Gelderblom, H.
    Grimer, R.
    Hall, K. Sundby
    Hassan, B.
    Hogendoorn, P. C. W.
    Jurgens, H.
    Paulussen, M.
    Rozeman, L.
    Taminiau, A. H. M.
    Whelan, J.
    Vanel, D.
    ANNALS OF ONCOLOGY, 2010, 21 : v204 - v213
  • [27] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Pacini, F.
    Castagna, M. G.
    Brilli, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 110 - 119
  • [28] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Haie-Meder, C.
    Morice, P.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v37 - v40
  • [29] Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Cascinu, S.
    Falconi, M.
    Valentini, V.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2010, 21 : v55 - v58
  • [30] Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Michielin, O.
    van Akkooi, A. C. J.
    Ascierto, P. A.
    Dummer, R.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1884 - 1901